Italian Study of Patients With Lymphoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-07

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is an observational, non-interventional, prospective, monocentric study, whose objective is to enroll 1500 patients with lymphoma in 5 years within the Institute of Hematology "Seragnoli".

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

NCT06781437

Lymphoproliferative Syndrome, Autoimmune Lymphoma

RECRUITING

Italian Multicenter Retrospective Observational Study on Transformed Lymphomas

NCT02927756

Non-Hodgkin Lymphoma Transformed Recurrent

UNKNOWN

Indolent Non Follicular Lymphomas Prognostic Project

NCT02904577

Indolent B-Cell Lymphomas

COMPLETED

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

NCT06024694

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

ACTIVE_NOT_RECRUITING

Primary Cardiac Lymphoma: Italian Multicenter Experience

NCT05819528

Primary Cardiac Lymphoma

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is aimed at enriching the data on the prognostic role of genetic and epidemiological factors associated with clinical and epidemiological data of patients; to identify factors that influence the evolution of the disease, such as lifestyle and occupational factors, as well as the type of treatment; to document the impact of the disease on quality of life and to provide a platform for future research projects.

Study-specific questionnaires will be administered to patients, both at baseline and during follow-up, which methodologically represent a useful tool in order to achieve these objectives.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 18 years at enrollment
* Diagnosis of lymphoma within 3 months of enrollment
* Patients may have been treated, as long as the initial diagnosis of lymphoma is within 3 months of enrollment
* Signing of the informed consent form